Phenobarbital 16.2 mg/1 (Phenobarbital TABLET) 16.2 mg/1

Phenobarbital 16.2 mg tablets are a barbiturate medication used for various therapeutic purposes. This oral medication is commonly associated with seizure management and sedation. Learn more about its uses and effects.

Strength

16.2 mg/1

Pack Size

100 TABLET in 1 BOTTLE, PLASTIC (13517-625-01)

Manufacturer / TM Owner

e5 Pharma, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Phenobarbital 16.2 mg tablets are primarily used for their anticonvulsant properties, helping to manage certain types of seizures. Additionally, they may be prescribed for their sedative effects to promote relaxation and sleep. What is phenobarbital used for? It is often utilized in the treatment of epilepsy and other conditions requiring seizure control.

Side Effects

Common effects of phenobarbital 16.2 mg tablets may include drowsiness, dizziness, and mild sedation. Some individuals may experience coordination difficulties or slowed reflexes. These effects can vary depending on the individual and their specific health conditions.

Precautions & Warnings

When handling phenobarbital 16.2 mg tablets, it is important to follow the guidance of a healthcare professional. This medication can cause drowsiness, so activities requiring alertness should be approached with caution. Always store the medication in a secure place, away from children and pets.

Avoid Interactions

Phenobarbital 16.2 mg tablets may interact with other medications, including alcohol and certain antidepressants. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, phenobarbital can affect the metabolism of other drugs, so monitoring is essential.

Frequently Asked Questions

Phenobarbital is primarily used for its anticonvulsant properties to manage seizures and for sedation purposes.

Phenobarbital 16.2 mg tablets are taken orally, typically as directed by a healthcare professional.

Common side effects may include drowsiness, dizziness, and mild sedation.

Yes, phenobarbital can interact with other medications, including alcohol and certain antidepressants.

Store phenobarbital tablets in a secure place, away from children and pets, and follow any specific storage instructions provided.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.